Catalyst Wire Dossier Catalyst Wire Dossier

ASP4058

ASP4058 · Astellas Pharma Global Development, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASP4058, covering 2013-12-02 to 2013-12-02. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP4058 Following Single Oral Doses [Phase 1]

See pricing